Clinical Trials Browser

NCT01413750 2024-11-12

Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer

Phase 2 Terminated

23 enrolled 10 charts

Stage IIIA Lung Non-Small Cell Cancer AJCC v7

NCT04190056 2023-08-31

Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer

Phase 2 Terminated

1 enrolled 4 charts

Breast

Anatomic Stage IV Breast Cancer AJCC v8

NCT03713320 2022-04-08

SOLAR

Phase 2 Terminated

37 enrolled 23 charts

DermatologicLymphoid

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Mycosis Fungoides, Neoplasms, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous

NCT03509207 2020-08-04

Vorinostat (SAHA) in Uterine Sarcoma

Phase 2 Terminated

3 enrolled 6 charts

GynecologicSarcoma

Leiomyosarcoma, Endometrial Stromal Tumors

NCT02395627 2020-07-07

Reversing Therapy Resistance With Epigenetic-Immune Modification

Phase 2 Terminated

38 enrolled 18 charts

Breast

Breast Neoplasms

NCT00958074 2018-10-18

Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma

Phase 2 Terminated

11 enrolled 11 charts

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT02419755 2018-03-07

Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies

Phase 2 Terminated

12 enrolled 10 charts

LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00818649 2017-12-28

Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Phase 2 Terminated

16 enrolled 7 charts

Classical hematologyMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT00882206 2017-12-28

Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic Leukemia

Phase 2 Terminated

15 enrolled 8 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01312818 2017-12-28

Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)

Phase 2 Terminated

2 enrolled 6 charts

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00673153 2017-06-01

Vorinostat and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

Phase 2 Terminated

31 enrolled 11 charts

Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT01267240 2017-04-14

Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Phase 2 Terminated

25 enrolled 9 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT00126451 2017-04-10

A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED)

Phase 2 Terminated

16 enrolled

BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT01578343 2016-04-15

ZOLINZA

Phase 2 Terminated

20 enrolled

Lymphoid

Recurrence, Lymphoma, Mantle-Cell

NCT01500538 2016-02-15

VEIL

Phase 2 Terminated

1 enrolled

Classical hematologyLymphoid

Lymphoma, Lymphoma, Follicular, Thrombocytopenia, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT00132002 2015-03-19

Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer

Phase 2 Terminated

14 enrolled 6 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00363883 2015-02-13

Vorinostat in Treating Patients With Locally Recurrent or Metastatic Cancer of the Urothelium

Phase 2 Terminated

14 enrolled 6 charts

Genitourinary

Localized Transitional Cell Cancer of the Renal Pelvis and Ureter

NCT01600742 2014-01-09

Vorinostat and Concurrent Whole Brain Radiotherapy for Brain Metastasis

Phase 2 Terminated

4 enrolled

CNS

Brain Neoplasms

NCT01194427 2013-05-17

A Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer

Phase 2 Terminated

2 enrolled 3 charts

Breast

Breast Neoplasms

NCT00810576 2012-08-07

Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's Lymphoma

Phase 2 Terminated

1 enrolled 3 charts

DermatologicLymphoid

Subcutaneous panniculitis-like T-cell lymphoma, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Enteropathy-Associated T-Cell Lymphoma